Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant

NCT07572929 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT07572929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07572929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
February 1, 2034
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, myelodysplastic syndromes, myeloid disorders, myeloproliferative neoplasm